Keros Therapeutics, Inc.
Ticker: KROS
| Insider | Title |
|---|---|
| (cayman) Iv L.p. Pontifax | 10% or greater ownership |
| (china) Iv L.p. Pontifax | 10% or greater ownership |
| (israel) Iv, L.p. Pontifax | 10% or greater ownership |
| Advisors Llc Orbimed | Director |
| Alpna Seth | Director |
| Capital Gp Vii Llc Orbimed | Director |
| Carl L Gordon | Director |
| Christopher Rovaldi | CHIEF OPERATING OFFICER |
| Claudia Ordonez | Chief Medical Officer |
| Genesis Gp Llc Orbimed | Director |
| Jasbir Seehra | CHIEF EXECUTIVE OFFICER, Director |
| Jean Jacques Bienaime | Director |
| Jennifer Lachey | Chief Scientific Officer |
| Julius Knowles | Director |
| Keith Regnante | CHIEF FINANCIAL OFFICER |
| Late Stage Fund L.p. Pontifax | 10% or greater ownership |
| Late Stage Gp Ltd. Pontifax | 10% or greater ownership |
| Management 4 G.p. (2015) Ltd. Pontifax | 10% or greater ownership |
| Mary Ann Gray | Director |
| Nima Farzan | Director |
| Ran Nussbaum | Director, 10% or greater ownership |
| Simon Peter Cooper | CHIEF MEDICAL OFFICER |
| Tomer Kariv | Director, 10% or greater ownership |
| Yung H. Chyung | Chief Medical Officer |